Mary-Jane Lombardo

1.1k total citations
7 papers, 738 citations indexed

About

Mary-Jane Lombardo is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Mary-Jane Lombardo has authored 7 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Genetics. Recurrent topics in Mary-Jane Lombardo's work include DNA Repair Mechanisms (3 papers), Gut microbiota and health (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Mary-Jane Lombardo is often cited by papers focused on DNA Repair Mechanisms (3 papers), Gut microbiota and health (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Mary-Jane Lombardo collaborates with scholars based in United States, Chile and Canada. Mary-Jane Lombardo's co-authors include Susan M. Rosenberg, P. J. Hastings, Gregory J. McKenzie, Peter L. Lee, Barbara McGovern, John Auniņš, Sahil Khanna, Jonathan Winkler, Marin Vulić and Christina Pindar and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Molecular Cell.

In The Last Decade

Mary-Jane Lombardo

6 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary-Jane Lombardo United States 6 509 307 213 105 89 7 738
Gwladys Sevrin France 2 270 0.5× 162 0.5× 120 0.6× 68 0.6× 32 0.4× 2 443
Tiphanie Faïs France 10 331 0.7× 78 0.3× 109 0.5× 49 0.5× 72 0.8× 11 477
Jyoti K. Jha United States 13 443 0.9× 196 0.6× 102 0.5× 56 0.5× 55 0.6× 21 701
Maëlle Prorok-Hamon France 4 276 0.5× 131 0.4× 116 0.5× 69 0.7× 33 0.4× 8 442
Sarah E. Anderson United States 12 204 0.4× 63 0.2× 167 0.8× 43 0.4× 88 1.0× 20 442
Xavier Duportet France 7 852 1.7× 200 0.7× 90 0.4× 38 0.4× 113 1.3× 8 1.0k
Sebastian Dintner Germany 11 196 0.4× 115 0.4× 83 0.4× 33 0.3× 76 0.9× 29 448
Monique DallʼAgnol United States 9 279 0.5× 105 0.3× 124 0.6× 40 0.4× 78 0.9× 10 618
Emilie Fargier Ireland 11 340 0.7× 114 0.4× 36 0.2× 42 0.4× 151 1.7× 12 864
Martina C. Haug Switzerland 11 255 0.5× 98 0.3× 44 0.2× 19 0.2× 30 0.3× 11 544

Countries citing papers authored by Mary-Jane Lombardo

Since Specialization
Citations

This map shows the geographic impact of Mary-Jane Lombardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary-Jane Lombardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary-Jane Lombardo more than expected).

Fields of papers citing papers by Mary-Jane Lombardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary-Jane Lombardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary-Jane Lombardo. The network helps show where Mary-Jane Lombardo may publish in the future.

Co-authorship network of co-authors of Mary-Jane Lombardo

This figure shows the co-authorship network connecting the top 25 collaborators of Mary-Jane Lombardo. A scholar is included among the top collaborators of Mary-Jane Lombardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary-Jane Lombardo. Mary-Jane Lombardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bryant, Jessica A., Timothy J. Straub, Darrell S. Pardi, et al.. (2025). Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection. The Journal of Infectious Diseases. 232(5). e733–e740.
2.
McChalicher, Christopher, et al.. (2022). Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool. Open Forum Infectious Diseases. 9(9). ofac448–ofac448. 14 indexed citations
3.
Khanna, Sahil, Darrell S. Pardi, Colleen Kelly, et al.. (2016). A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents RecurrentClostridium difficileInfection. The Journal of Infectious Diseases. 214(2). 173–181. 230 indexed citations
4.
Mamun, Abu Amar M. Al, Mary-Jane Lombardo, Chandan Shee, et al.. (2012). Identity and Function of a Large Gene Network Underlying Mutagenic Repair of DNA Breaks. Science. 338(6112). 1344–1348. 172 indexed citations
5.
Lombardo, Mary-Jane, Jane M. Michalski, Hector Martinez-Wilson, et al.. (2007). An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers. Proceedings of the National Academy of Sciences. 104(46). 18229–18234. 72 indexed citations
6.
McKenzie, Gregory J., Peter L. Lee, Mary-Jane Lombardo, P. J. Hastings, & Susan M. Rosenberg. (2001). SOS Mutator DNA Polymerase IV Functions in Adaptive Mutation and Not Adaptive Amplification. Molecular Cell. 7(3). 571–579. 236 indexed citations
7.
Lombardo, Mary-Jane, et al.. (1999). Mechanisms of Genome‐Wide Hypermutation in Stationary Phasea. Annals of the New York Academy of Sciences. 870(1). 275–289. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026